Mitophagy suppression via lncRNA H19 silencing: a novel strategy to overcome cisplatin resistance in lung adenocarcinoma.

Saved in:
Bibliographic Details
Title: Mitophagy suppression via lncRNA H19 silencing: a novel strategy to overcome cisplatin resistance in lung adenocarcinoma.
Authors: Liu MZ; Department of Medical Oncology, Southeast University Affiliated Xuzhou Central Hospital, Xuzhou, China.; Department of Medical Oncology, Xuzhou Central Hospital, Clinical School of Xuzhou Medical University, Xuzhou, China.; Department of Internal Medicine, Zhumadian Central Hospital, Zhumadian, China., Shao XY; Department of Medical Oncology, Southeast University Affiliated Xuzhou Central Hospital, Xuzhou, China.; Department of Medical Oncology, Xuzhou Central Hospital, Clinical School of Xuzhou Medical University, Xuzhou, China., Wu SH; Department of Medical Oncology, Southeast University Affiliated Xuzhou Central Hospital, Xuzhou, China.; Department of Medical Oncology, Xuzhou Central Hospital, Clinical School of Xuzhou Medical University, Xuzhou, China., Ning QQ; Department of Molecular Microbiology and Immunology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA., Zhang C; Department of Medical Oncology, Southeast University Affiliated Xuzhou Central Hospital, Xuzhou, China.; Department of Medical Oncology, Xuzhou Central Hospital, Clinical School of Xuzhou Medical University, Xuzhou, China., Du WW; Department of Medical Oncology, Southeast University Affiliated Xuzhou Central Hospital, Xuzhou, China.; Department of Medical Oncology, Xuzhou Central Hospital, Clinical School of Xuzhou Medical University, Xuzhou, China., Sun RR; Department of Medical Oncology, Southeast University Affiliated Xuzhou Central Hospital, Xuzhou, China.; Department of Medical Oncology, Xuzhou Central Hospital, Clinical School of Xuzhou Medical University, Xuzhou, China., Sun SY; Department of Medical Oncology, Southeast University Affiliated Xuzhou Central Hospital, Xuzhou, China.; Department of Medical Oncology, Xuzhou Central Hospital, Clinical School of Xuzhou Medical University, Xuzhou, China., Zhang YW; Department of Medical Oncology, Southeast University Affiliated Xuzhou Central Hospital, Xuzhou, China.; Department of Medical Oncology, Xuzhou Central Hospital, Clinical School of Xuzhou Medical University, Xuzhou, China.
Source: Cell cycle (Georgetown, Tex.) [Cell Cycle] 2025 Nov-Dec; Vol. 24 (21-24), pp. 670-686. Date of Electronic Publication: 2025 Nov 05.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137841 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1551-4005 (Electronic) Linking ISSN: 15514005 NLM ISO Abbreviation: Cell Cycle Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1551-4005
DOI:10.1080/15384101.2025.2581634